The anti-PD-1/PD-L1 mAbs and chemotherapy groups had no significant differences in RR for all-grade increased blood creatinine and AKI and no significant differences for high-grade increased blood creatinine and AKI (Fig. S1 and Table S1). The gene discussed is CD274; the disease is acute kidney injury.